Wordt geladen...
Anabolic Therapies
The striking clinical benefits of intermittent parathyroid hormone in osteoporosis have begun a new era of skeletal anabolic agents. Recombinant human parathyroid hormone (rhPTH) (1–34) is the first US Food and Drug Administration–approved anabolic therapy. Its use has been limited by the need for s...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Current Science Inc.
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2841260/ https://ncbi.nlm.nih.gov/pubmed/20425087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11914-010-0005-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|